SCHEMBL4037097

SCHEMBL4037097

O=c1[nH]c(=O)c2c(nc(O)n2O)[nH]1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GDA Q9Y2T3 2/20 0.41
RPS6KA3 P51812 2/20 0.34
BLM P54132 2/20 0.33
TDP1 Q9NUW8 2/20 0.33
ADORA2B P29275 2/20 0.33
KDM4E B2RXH2 2/20 0.33
ALDH1A1 P00352 2/20 0.33
CYP1A2 P05177 2/20 0.33
HSD17B10 Q99714 2/20 0.33
DPP4 P27487 1/20 0.33
PABPC1 P11940 1/20 0.33
ADORA2A P29274 1/20 0.33
CYP2C19 P33261 1/20 0.33
RAB9A P51151 1/20 0.33
CASP7 P55210 1/20 0.33
PMP22 Q01453 1/20 0.33
BRDT Q58F21 1/20 0.33
PIK3CG P48736 1/20 0.33
MAPT P10636 3/20 0.32
ACHE P22303 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7004955 0.65 GDA (0.49) GDARPS6KA3BLMTDP1ADORA2B
SCHEMBL18989874 0.64 GDA (0.47) GDARPS6KA3BLMTDP1ADORA2B
SCHEMBL5518489 0.61 GDA (0.62) GDABLMTDP1ADORA2BKDM4E
Uric Acid SCHEMBL2786719 0.61 MAPT (0.53) GDARPS6KA3BLMTDP1ADORA2B
SCHEMBL1681856 0.61 GDA (0.44) GDARPS6KA3BLMTDP1ADORA2B
SCHEMBL21389576 0.61 GDA (0.40) GDATDP1KDM4EALDH1A1DPP4
SCHEMBL31715084 0.61 POLB (0.42) GDATDP1KDM4EALDH1A1CYP1A2
SCHEMBL4869377 0.60 KDM4E (0.55) GDABLMTDP1ADORA2BKDM4E
SCHEMBL16495784 0.60 GDA (0.39) GDARPS6KA3BLMTDP1ADORA2B
SCHEMBL7004643 0.60 GDA (0.39) GDARPS6KA3BLMTDP1ADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1601673-B1 FUSED HETEROCYCLES AND USES THEREOF ASTRAZENECA AB (SE) 2009-06-10 EP claimed
EP-1230243-B1 POYCYLOALKYLPURINES AS ADENOSINE RECEPTOR ANTAGONISTS BIOGEN IDEC INC (US) 2009-03-04 EP claimed